Bomb Report – Lifestyle
Author:
Royalty Pharma plc
Royalty Pharma Declares Second Quarter 2026 Dividend
April 17, 2026
Royalty Pharma to Announce First Quarter 2026 Financial Results on May 6, 2026
April 15, 2026
Royalty Pharma Announces R&D Funding Collaboration for Chronic Immune-Mediated Diseases
March 30, 2026
Royalty Pharma Appoints Lucas Glass as Head of Artificial Intelligence
March 23, 2026
Royalty Pharma Announces Expansion of Leadership Team
March 17, 2026
Royalty Pharma Appoints Kenneth Sun as Senior Vice President and Head of Asia to Expand Royalty Pharma’s Global Platform
March 6, 2026
Royalty Pharma and Zymeworks Enter Into $250 Million Royalty-Backed Note Financing
March 6, 2026
Royalty Pharma to Present at TD Cowen’s 46th Annual Health Care Conference
March 5, 2026